The Vaccine World Summit India 2013 conference has honored Novavax, Cadila Pharmaceuticals Biologicals (CPLB) and the International Centre for Genetic Engineering and Biotechnology (ICGEB) collaboration for having the 'most promising ...
Tags: malaria vaccine, Pharmaceuticals, Vaccine
Novavax has reported a net loss of $7.22m, or $0.05 per share, for the third quarter ended 30 September 2012 compared to a net loss of $3.21m, or $0.03 per share, for the third quarter ended 30 September 2011. Revenue for third quarter of ...
Tags: Novavax, Wider Q3 Net Loss, net loss, clinical trials